Biology Reference
In-Depth Information
Stamenkovic, I, Yu, Q., 2010. Merlin, a “Magic” linker between the extracellular cues and
intracellular signaling pathways that regulate cell motility, proliferation, and survival.
Curr. Protein Pept. Sci. 11, 471-484.
Stark, A.M., Tongers, K., Maass, N., Mehdorn, H.M., Held-Feindt, J., 2005. Reduced metasta-
sis-suppressor gene mRNA-expression in breast cancer brain metastases. J. Cancer Res.
Clin. Oncol. 131, 191-198.
St Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K.E., Montgomery, E., et  al.,
2000. Genes expressed in human tumor endothelium. Science 289, 1197-1202.
Stein, S., Thomas, E.K., Herzog, B., Westfall, M.D., Rocheleau, J.V., Jackson, R.S., et al., 2004.
NDRG1 is necessary for p53-dependent apoptosis. J. Biol. Chem. 279, 48930-48940.
Stein, U., Arlt, F., Walther, W., Smith, J., Waldman, T., Harris, E.D., et al., 2006. The metas-
tasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in
colon cancer. Gastroenterology 131, 1486-1500.
Stein, U., Arlt, F., Smith, J., Sack, U., Herrmann, P., Walther, W., et al., 2011. Intervening in
beta-catenin signaling by Sulindac inhibits S100A4-dependent colon cancer metastasis.
Neoplasia 13, 131-144.
Strand, M.F., Wilson, S.R., Dembinski, J.L., Holsworth, D.D., Khvat, A., Okun, I., et  al.,
2011. A novel synthetic Smoothened antagonist transiently inhibits pancreatic adenocar-
cinoma xenografts in a mouse model. PloS ONE 6, e19904.
Straza, M.W., Paliwal, S., Kovi, R.C., Rajeshkumar, B., Trenh, P., Parker, D., et  al. 2010.
Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle 9,
3740-3750.
Stengel, K., Zheng, Y., 2011. Cdc42 in oncogenic transformation, invasion, and tumorigenesis.
Cell Signal. 23, 1415-1423.
Strappel, M.M., Vincent, A., Mukherjee, R., Campbell, N.R., Chen, S.H., Konstantopoulos,
K., et al., 2012. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines
and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus,
stomach, and colon. Human Pathol. 43, 1755-1763.
Strazisar, M., Mlakar, V., Rott, T., Glavac, D., 2009. Somatic alterations of the serine/threo-
nine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma.
Cancer Invest. 27, 407-416.
Strzelczyk, B., Szulc, A., Rzepko, R., Kitowska, A., Skokowski, J., Szutowicz, A., et  al.,
2009. Identification of high-risk stage II colorectal tumors by combined analysis of
the NDRG1 gene expression and the depth of tumor invasion. Ann. Surg. Oncol. 16,
1287-1294.
Su, C.H., Zhao, R., Zhang, F., Qu, C., Chen, B., Feng, Y.H., et al., 2011. 14-3-3 sigma exerts
tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res. 71,
884-894.
Subramanian, C., Jarzembowski, J.A., Opipari Jr, A.W., Castle, V.P., Kwok, R.P.S., 2011.
HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma. Neoplasia
13, 726-734.
Sugimoto, S., Maass, N., Takimoto, Y., Sato, K., Minei, S., Zhang, M., et al., 2004. Expression
and regulation gene maspin in human of tumor suppressor bladder cancer. Cancer Lett.
203, 209-215.
Suh, S.O., Chen, Y., Zaman, M.S., Hirata, H., Yamamura, S., Shahryari, V., et  al., 2011.
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate can-
cer. Carcinogenesis 32, 772-778.
Sum, E.Y.M., Peng, B., Yu, X., Chen, J.J., Byrne, J., Lindeman, G.J., et  al., 2002. The LIM
domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1
and inhibits BRCA1 activity. J. Biol. Chem. 277, 7849-7856.
 
Search WWH ::




Custom Search